Lemaitre Vascular INC Form 4 insider transactions

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular Inc., reported gifting 21,200 shares of common stock and accruing new dividend equivalent rights.

A director at Lemaitre Vascular Inc. reported a future planned sale of 976 shares of common stock, executed under a pre-arranged trading plan.

Lemaitre Vascular President and Director David B. Roberts exercised stock options and subsequently sold an equivalent number of shares.

A director at LEMAITRE VASCULAR INC exercised stock options and subsequently sold 2,500 shares of common stock as part of a pre-planned trading arrangement.

A director at LEMAITRE VASCULAR INC exercised stock options and subsequently sold a significant number of shares in early August 2025.

LeMaitre Vascular's Chairman and CEO, George W. LeMaitre, plans to sell 100,000 shares of common stock on August 6, 2025, under a pre-arranged 10b5-1 plan.

Martha Shadan, a Director at Lemaitre Vascular Inc. (LMAT), reported the accrual of additional dividend equivalent rights tied to her existing restricted stock and performance share unit awards.

Lemaitre Vascular Inc. Director John A. Roush reported the accrual of additional dividend equivalent rights tied to his existing restricted stock unit and performance share unit awards.

Bridget A. Ross, a Director at Lemaitre Vascular Inc., has reported the acquisition of dividend equivalent rights tied to her existing equity awards, as detailed in a recent SEC Form 4 filing.

Lemaitre Vascular Inc. Director John James O'Connor reported the acquisition of additional dividend equivalent rights tied to previously granted equity awards.

Lemaitre Vascular Inc. Director Lawrence J. Jasinski reported the acquisition of dividend equivalent rights tied to his restricted and performance stock unit awards on May 29, 2025, as part of his ongoing compensation.

Trent G. Kamke, Senior V.P., Operations at Lemaitre Vascular Inc., reported the acquisition of various dividend equivalent rights tied to his restricted stock and performance share unit awards on May 29, 2025, as part of his ongoing compensation.

Lemaitre Vascular's Chief Financial Officer, Dorian Paul LeBlanc, reported the acquisition of 3.0197 dividend equivalent rights, linked to a restricted stock unit award, on May 29, 2025.

Lemaitre Vascular Inc. Director Joseph P. Pellegrino Jr. has reported the acquisition of various dividend equivalent rights tied to previously granted restricted stock and performance share unit awards.

David B. Roberts, President and Director of Lemaitre Vascular Inc., reported the acquisition of additional dividend equivalent rights linked to his existing restricted stock and performance share unit awards.

LeMaitre Vascular Inc.'s Chairman and CEO, George W. LeMaitre, acquired additional dividend equivalent rights on May 29, 2025, linked to his existing restricted stock and performance share unit awards.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, Inc., reported multiple transactions involving the company's common stock, including sales and option exercises, between May 16 and May 20, 2025.

Director Ross Bridget A. of Lemaitre Vascular exercised stock options and sold shares on May 12, 2025.

Director Martha Shadan reports acquiring dividend equivalent rights related to restricted stock units and performance share units.

Director John A. Roush reports the acquisition of dividend equivalent rights related to restricted stock units and performance share units of LeMaitre Vascular Inc.

Director Bridget A. Ross reported the acquisition of dividend equivalent rights related to restricted stock units and performance share units.

John James O'Connor, a director at LeMaitre Vascular Inc., reports changes in beneficial ownership due to the acquisition of dividend equivalent rights.

Director Lawrence J. Jasinski reports the acquisition of dividend equivalent rights related to restricted stock units and performance stock units.

Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular Inc., reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

Chief Financial Officer Dorian Paul LeBlanc reports the acquisition of dividend equivalent rights related to a restricted stock unit award.

Director Joseph P. Pellegrino JR. acquired dividend equivalent rights related to restricted stock unit awards and performance share units.

David B. Roberts, a director and officer at Lemaitre Vascular, acquired dividend equivalent rights related to restricted stock units and performance share units on March 27, 2025.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

Chief Financial Officer Dorian Paul LeBlanc reports acquiring 1,221 shares of LeMaitre Vascular Inc. common stock on March 10, 2025, through a restricted stock unit award.

Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular Inc., reports exercising stock options and selling shares of common stock between March 12 and March 14, 2025.